The Food and Drug Administration (FDA) has approved Romvimza ™ (vimseltinib) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will ...

Jade Collett thought she’d “twinged a nerve” — but she had a terminal tumor pressing on the part of the brain that controls ...

The apparent benefits at 2 years observed in the nonrandomized ALT-FLOW study pave the way for a sham-controlled trial.

For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after successful ...

RXRX is expected to provide updates on its oncology and rare disease pipeline in its fourth-quarter earnings release, given ...

Data from the Texas Department of State Health Services reported 58 measles cases have been identified over the last three ...

Minimally invasive heart procedures like transcatheter aortic valve replacement (TAVR) and MitraClip placement to treat mitral regurgitation can improve quality of life, and even be lifesaving, for ...

The study, “Seroprevalence of Highly Pathogenic Avian Influenza A (H5) Virus Infections Among Bovine Veterinary Practitioners ...

Priority Review Vouchers (PRVs) are transferable and, in past transactions by other companies, have sold for prices up to $350 million ...

Two hernia 'super clinics' have helped to cut waiting times at Oxford University Hospitals by seeing more than 400 patients for appointments.

Poster highlights robust, dose-dependent endoscopic response with VTX958 and reductions in key inflammatory markers Full analysis of Phase 2 results, including data from the 52-week treat-through LTE ...

Avelumab maintenance with axitinib interruption was feasible in metastatic renal cell carcinoma responders, according to ...